These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20667570)

  • 1. Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.
    Schaap-Nutt A; D'Angelo C; Amaro-Carambot E; Nolan SM; Davis S; Wise SM; Higgins C; Bradley K; Kim O; Mayor R; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC
    Virology; 2010 Oct; 406(1):65-79. PubMed ID: 20667570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.
    Schaap-Nutt A; D'Angelo C; Scull MA; Amaro-Carambot E; Nishio M; Pickles RJ; Collins PL; Murphy BR; Schmidt AC
    Virology; 2010 Feb; 397(2):285-98. PubMed ID: 19969320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.
    Schaap-Nutt A; Higgins C; Amaro-Carambot E; Nolan SM; D'Angelo C; Murphy BR; Collins PL; Schmidt AC
    J Virol; 2011 Apr; 85(8):4007-19. PubMed ID: 21289116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons.
    Andrejeva J; Young DF; Goodbourn S; Randall RE
    J Virol; 2002 Mar; 76(5):2159-67. PubMed ID: 11836393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acids essential for the human parainfluenza type 2 virus V protein to lower the intracellular levels of the STAT2.
    Kozuka Y; Yamashita Y; Kawano M; Tsurudome M; Ito M; Nishio M; Komada H; Ito Y
    Virology; 2003 Dec; 317(2):208-19. PubMed ID: 14698661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.
    Bartlett EJ; Cruz AM; Esker J; Castaño A; Schomacker H; Surman SR; Hennessey M; Boonyaratanakornkit J; Pickles RJ; Collins PL; Murphy BR; Schmidt AC
    J Virol; 2008 Sep; 82(18):8965-77. PubMed ID: 18614629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain.
    Kawano M; Kaito M; Kozuka Y; Komada H; Noda N; Nanba K; Tsurudome M; Ito M; Nishio M; Ito Y
    Virology; 2001 May; 284(1):99-112. PubMed ID: 11352671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.
    Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM
    Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.
    Young DF; Didcock L; Goodbourn S; Randall RE
    Virology; 2000 Apr; 269(2):383-90. PubMed ID: 10753717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.
    Nolan SM; Skiadopoulos MH; Bradley K; Kim OS; Bier S; Amaro-Carambot E; Surman SR; Davis S; St Claire M; Elkins R; Collins PL; Murphy BR; Schaap-Nutt A
    Vaccine; 2007 Aug; 25(34):6409-22. PubMed ID: 17658669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness.
    Nishio M; Ohtsuka J; Tsurudome M; Nosaka T; Kolakofsky D
    J Virol; 2008 Jul; 82(13):6130-8. PubMed ID: 18417591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.
    Nishio M; Tsurudome M; Ito M; Garcin D; Kolakofsky D; Ito Y
    J Virol; 2005 Jul; 79(13):8591-601. PubMed ID: 15956600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.
    Parisien JP; Lau JF; Horvath CM
    J Virol; 2002 Jul; 76(13):6435-41. PubMed ID: 12050355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2.
    Goto H; Ihira H; Morishita K; Tsuchiya M; Ohta K; Yumine N; Tsurudome M; Nishio M
    Med Microbiol Immunol; 2016 Jun; 205(3):209-18. PubMed ID: 26582554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2.
    Precious B; Young DF; Andrejeva L; Goodbourn S; Randall RE
    J Gen Virol; 2005 Jan; 86(Pt 1):151-158. PubMed ID: 15604442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
    Durbin AP; McAuliffe JM; Collins PL; Murphy BR
    Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parainfluenza virus type 2 V protein inhibits caspase-1.
    Ohta K; Matsumoto Y; Nishio M
    J Gen Virol; 2018 Apr; 99(4):501-511. PubMed ID: 29485395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
    Bartlett EJ; Cruz AM; Boonyaratanakornkit J; Esker J; Castaño A; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC
    Vaccine; 2010 Jan; 28(3):767-79. PubMed ID: 19857454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1.
    Van Cleve W; Amaro-Carambot E; Surman SR; Bekisz J; Collins PL; Zoon KC; Murphy BR; Skiadopoulos MH; Bartlett EJ
    Virology; 2006 Aug; 352(1):61-73. PubMed ID: 16750233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.
    Fros JJ; Liu WJ; Prow NA; Geertsema C; Ligtenberg M; Vanlandingham DL; Schnettler E; Vlak JM; Suhrbier A; Khromykh AA; Pijlman GP
    J Virol; 2010 Oct; 84(20):10877-87. PubMed ID: 20686047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.